OA08.07 Sacituzumab Govitecan + Pembrolizumab + Carboplatin in 1L Metastatic Non-Small Cell Lung Cancer: The EVOKE-02 Study

Autor: Gray, J., Neal, J., Patel, J.D., Liu, S.V., Girard, N., Reck, M., Cappuzzo, F., Cobo Dols, M., Reguart, N., Fuentes Pradera, J., Cho, B.C., Li, M., Mekan, S., Safavi, F., Fernando, N., Karumanchi, D., Chisamore, M., Garon, E.B.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S27-S27
Databáze: ScienceDirect